Subscribe to this collection to receive daily e-mail notification of new additions

	Title	Author(s)	Issue Date	Views
	IMMUNOTHERAPEUTIC TARGETS AGAINST STAPHYLOCOCCUS AUREUS	HUANG JIAN-DONGYUEN KWOK-YUNGZHANG BAOZHONG	2016	114
	IMMUNOTHERAPEUTIC TARGETS AGAINST STAPHYLOCOCCUS AUREUS	HUANG, JIANDONGYUEN, KWOK YUNGZHANG, BAOZHONG	2016	179
	Cadherin-17 as diagnostic marker and therapeutic target for liver cancer	LUK MOON CHING JOHNLEE PUI YUE NIKKILIU LINGXIAOPOON TUNG PING RONNIEFAN SHEUNG TAT	2012	128
	Self-assembling peptides for promoting hemostasis	ELLIS-BEHNKE, RUTLEDGEZHANG, SHUGUANGSCHNEIDER, GERALDSO, KWOK-FAITAY, DAVIDLIANG, YU-XIANG	2008	127
	Flow through nucleic acid hybridisation device	TAM, JOSEPH WING ON	2000	93
	Compositions and methods for promoting hemostasis and other physiological activities	ELLIS-BEHNKE, RUTLEDGELIANG, YU-XIANGSCHNEIDER, GERALD ESO, KWOK-FAITAY, DAVID K.CZHANG, SHUGUANG	2011	117
	Use of Annexin A3 as a Diagnostic and Prognostic Biomarker and Therapeutic Target for Treating Hepatocellular Carcinoma	GUAN XIN-YUANMA STEPHANIE KWAI YEETONG MAN	2015	171
	THERAPEUTIC DELIVERY AND EXPRESSION SYSTEM, METHODS AND USES THEREOF	HUANG JIAN-DONGSHI LEIYU BIN	2015	105
	High-affinity nucleic acid aptamers against sclerostin protein	CHAN SZELAI CELINESHUM KATOTANNER JULIAN ALEXANDER	2013	114
	Compositions and methods for promoting hemostasis and other physiological activities	ELLIS-BEHNKE RUTLEDGELIANG YU-XIANGSCHNEIDER GERALDSO KWOK-FAITAY DAVIDZHANG SHUGUANG	2007	98
	Compositions and methods for affecting movement of contaminants, bodily fluids or other entities, and/or affecting other physiological conditions	ELLIS-BEHNKE RUTLEDGELIANG YU-XIANGSCHNEIDER GERALD ESO KWOK-FAITAY DAVID	2008	92
	COMPOSITIONS AND METHODS FOR PROMOTING HEMOSTASIS AND OTHER PHYSIOLOGICAL ACTIVITIES	DAVID TAYGERALD SCHNEIDERLIANG YU-XIANGRUTLEDGE ELLIS-BEHNKESO KWOK-FAIZHANG SHUGUANG	2014	135
	COMPOSITIONS AND METHODS FOR AFFECTING MOVEMENT OF CONTAMINANTS, BODILY FLUIDS OR OTHER ENTITIES AND/OR AFFECTING OTHER PHYSIOLOGICAL CONDITIONS	ELLIS-BEHNKE, RUTLEDGELIANG, YU-XIANGSCHNEIDER, GERALD ESO, KWOK-FAITAY, DAVID	2007	109
	Flow through nucleic acid hybridisation uses thereof and a device thereof	TAM, JOSEPH WING ON	1998	92
	USE OF ANNEXIN A3 AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER AND THERAPEUTIC TARGET FOR TREATING HEPATOCELLULAR CARCINOMA	GUAN, XINYUANMA, KWAI YEE STEPHANIETONG, MAN	2015	127
	Bioengineered Intervertebral Discs and Methods for Their Preparation	Chan, BPCheung, KMCChan, DChan, GCFHui, TY	2007	106
	Cell-Matrix Microspheres, Methods for Preparation and Applications	Chan, BPChan, GCFWong, HLCheung, PTCheah, KSEChan, D	2014	104
	TWO-WAY, PORTABLE RIBOSWITCH MEDIATED GENE EXPRESSION CONTROL DEVICE	HUANG, JIAN-DONGJIN, YE	2013	561
	Lamin A, An Activator of Longevity/Anti-Aging SIRT1 Protein	ZHOU, ZHONGJUNLIU, BAOHUA	2014	85
	NUCLEIC ACID APTAMERS AGAINST PLASMODIUM LACTATE DEHYDROGENASE AND HISTIDINE-RICH PROTEIN II AND USES THEREOF FOR MALARIA DIAGNOSIS	TANNER, JULIAN ACHEUNG, YEE WAIKOTAKA MASAYO	2013	96